Source: Citybizlist

Atem Capital: Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners

LYON, France and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) - Amolyt Pharma, a global company specialized in developing therapeutic... Read MoreThe post Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners appeared first on citybiz.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Anton Gopka's photo - CEO of Atem Capital

CEO

Anton Gopka

CEO Approval Rating

85/100

Read more